Filing Details
- Accession Number:
- 0001161697-22-000400
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-19 17:03:19
- Reporting Period:
- 2022-08-18
- Accepted Time:
- 2022-08-19 17:03:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369568 | Catalyst Pharmaceuticals Inc. | CPRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1402535 | Steve Miller | 355 Alhambra Circle, Suite 801 Coral Gables FL 33134 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2022-08-18 | 118,575 | $2.53 | 880,299 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2022-08-18 | 118,575 | $13.56 | 761,724 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2022-08-18 | 31,425 | $2.53 | 793,149 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2022-08-18 | 31,425 | $13.43 | 761,724 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to purchase common stock | Disposition | 2022-08-18 | 118,575 | $0.00 | 118,575 | $2.53 |
| Common Stock | Options to purchase common stock | Disposition | 2022-08-18 | 31,425 | $0.00 | 31,425 | $2.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,492,425 | 2022-12-30 | No | 4 | A | Direct | |
| 1,461,000 | 2022-12-30 | No | 4 | A | Direct |
Footnotes
- Shares were sold in various lots from $13.37 to $13.66 per share. The listed sales price represents a weighted average price for the shares sold.
- Shares were sold in various lots from $13.30 to $13.54 per share. The listed sales price represents a weighted average price for the shares sold.
- Shares were sold to cover exercise price of options, tax withholding requirements (if applicable) and for personal reasons. Shares were not sold as a result of any disagreement with the Company and Dr. Miller remains an officer of the Company.
- Options vested in three annual tranches beginning on December 30, 2016.
Billionaire Hedge Funds
